DEADLINE EXTENDED TO SEPTEMBER 12 - DON'T MISS YOUR CHANCE! |
|
|
| |
Dear E,
We've got great news - the submission deadline for the 2024 Fierce Life Sciences Innovation Awards has been extended to September 12th! These prestigious awards offer you a platform to elevate your innovation and connect with industry leaders. ​ Click here to read about our past winners.
If you've already started your submission, now is the time to complete and submit it. This will be your last chance to get your groundbreaking innovation recognized and celebrated. |
|
|
| SUBMIT NOW | | | Why Submit? - Industry Recognition: Gain visibility and recognition from industry leaders, peers, and potential partners
- Credibility: Enhance your brand’s credibility and reputation by being associated with excellence and innovation
- Networking Opportunities: Connect with other innovators, key stakeholders, and decision-makers in the healthcare and life sciences sectors
- Media Exposure: Benefit from extensive media coverage, including features in Fierce Healthcare and Fierce Life Sciences publications
- Talent Attraction: Attract top talent by showcasing your commitment to innovation and excellence
- Motivation for Your Team: Celebrate your team’s hard work and achievements, boosting morale and motivation.
| | |
|
|
| |
We are thrilled to announce an additional submission category for the Fierce Life Sciences Innovation Awards: ​ AI Innovation ​ Advancing drug development through artificial intelligence. This category highlights the use of AI technologies to drive novel discoveries, optimize biotechnological processes, and enhance research and development efforts. |
|
|
| |
- AI Innovation
- Biotech Innovation
- Data Analytics/Business Intelligence
- Drug Delivery Technology
|
|
- Digital Health Solutions
- Medical Device Innovation
- Technology Innovation
|
|
|
| |
| |
2024 Key Dates & Information - Entry Fee: $575
- Submission Deadline: September 12
- Finalists Announced: October 22
- Winners Announced: November 27
Stay up-to-date and join our mailing list! |
|
|
| |
| |
| |
